TALKING EDGE: Duopharma’s long-term vaccine plan

Duopharma Biotech’s deal to supply the Sputnik V vaccine will undoubtedly be a game changer for the company. We talk to group MD Leonard Ariff Shatar about the details behind the deal, plans post-Covid-19, and whether the private sector should even be involved at all in the vaccine rollout.